Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology company specializing in musculoskeletal healthcare ...

Zimmer Biomet said on Tuesday it would acquire medical device company Paragon 28 for about $1.1 billion to expand its portfolio of orthopedic surgical devices. The deal will give Zimmer Biomet access ...

With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace ...

Zimmer Biomet (NYSE: ZBH) shares dipped slightly today on fourth-quarter results that came in just ahead of the consensus ...

The company expects 2025 adjusted profit to be in the range of $8.15 to $8.35 per share, compared with the average of ...

Expanding on the traditional triple-taper design, Zimmer Biomet has launched the Z1™ Femoral Hip System, a design that ...

Straumann, Dentsply Sirona, Zimmer Biomet, Henry Schein, Envista, Dentium, and Osstem Implant are some of the key vendors and these large multinational corporations dominate the market ...

BTIG analyst Ryan Zimmerman has maintained their bullish stance on ZBH stock, giving a Buy rating on January 23.Invest with Confidence: Follow ...

In a report released today, Caitlin Cronin from Canaccord Genuity maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report), ...

Unveiling the Story Behind Zimmer Biomet Holdings Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery.

The deal will give Zimmer Biomet access to Paragon's surgical implants and equipment used to treat foot and ankle ailments, while bolstering its fracture and trauma, and joint replacement businesses.